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To the Editor: Shared decision-making and decision aids can reduce healthcare utilization while 16 
improving patient satisfaction and adherence.1 Little is known about patient-preferred modalities 17 
of education in dermatology to facilitate shared decision-making. Here, we examine the impact 18 
of patient characteristics, including generational status, on preferences of learning modality and 19 
information sources when making treatment decisions in dermatology.  20 
 21 
We surveyed patients over 18 years of age at Brigham & Women’s Hospital Dermatology in 22 
August 2016, asking patients to rate on a five-point scale preferences for 1) learning modalities 23 
and 2) information sources when deciding on treatment for skin growths. Patients were not 24 
required to have prior history of any skin condition and participation was optional. Demographic 25 
and clinical data were extracted from manual chart review. Generation groupings were defined as 26 
Millennials (born 1981-1997), Generation X (born 1965-1980), Baby Boomers (born 1946-27 
1964), and the Silent Generation (born 1928-1945).2 Participants born outside of groupings (n=6) 28 
were combined into the closest group. Responses of 5 on the five-point scale were considered 29 
“most preferred” for learning preferences while responses of 4 or 5 were interpreted as 30 
“important” for information sources based on distributions of answers. Comparisons were 31 
performed using chi-square tests, and statistical significance was determined using Cochran-32 
Armitage trend tests. Analyses were performed using SAS 9.4 (SAS Institute, Cary, NC) and 33 
data were stored using “Research Electronic Data Capture”.3 34 
 35 
A total of 458 surveys were administered, of which 375 (82%) were completed. In-person 36 
discussion was the most popular learning modality (most preferred by 84.3% of participants, 37 
n=311), followed by diagrams/charts (14.5%, n=48), short handouts (11.6%, n=39), short videos 38 
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(10.4%, n=35), and phone conversation (8.1%, n=27) (Table 2). Information sources considered 39 
“important” were: recommendation from doctors (99.2%, n=370), patients’ past experiences 40 
(64.7%, n=189), patients’ personal preferences (55.3%, n=183), recommendations from 41 
friends/family (22.5%, n=74), and how other patients decide (22.2%, n=73). Millennials were 42 
more likely than other generations to rate personal experiences, personal preferences, 43 
recommendations from family/friends, and other patients’ experiences as important (p<0.05).  44 
 45 
This study identifies patient preferred learning modalities and information sources when 46 
deciding about skin growth treatment options. In-person discussion was the most popular 47 
learning modality, while phone conversation was the least. Diagrams/charts were favored over 48 
short handouts or videos and may serve as useful tools for future decision aids. 49 
 50 
There was an age-dependent valuing of non-physician peer-driven experiences by younger 51 
generations (Millennials > Generation X > Baby Boomers/Silent Generation), reflecting 52 
emphasis on connectivity (e.g. social media) and consumer-driven reviews/experiences (e.g. 53 
Yelp) by younger generations. Although in-person consultation is currently preferred by patients, 54 
these findings suggest that the presence of peer-driven ratings of physicians, hospitals, and even 55 
medical procedures available online may increasingly influence patient decision-making over 56 
time.4 Future education efforts may benefit from harnessing social media. 57 
 58 
Our findings are limited by a potential lack of generalizability and by differences in 59 
demographic/clinical variables between generations that may impact preference differences. 60 
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However, we believe that our study offers insight into patient decision-making, informing future 61 
efforts for decision aids and shared-decision making. 62 
  63 
 64 
 65 
 66 
 67 
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Table 1: Participant characteristics by generation 89 
 Overall 
n=375 
Millennials 
n=101 
Generation 
X 
N=77 
Baby 
Boomers & 
The Silent 
Generation 
N=197 
p-value 
Age, mean (SD) 51.4 
(18.9) 
27.2 (4.8) 43.5 (4.9) 67.3 (8.7) -- 
Female, n (%) 229 
(61.1) 
70 (69.3) 48 (62.3) 111 (56.3) 0.091 
Insurance, n (%)      
   Private 231 
(61.6) 
84 (83.2) 64 (83.1) 83 (42.1) 
<0.001    Medicare 93 (24.8) 0 (0.0) 2 (2.6) 90 (45.7) 
   Medicaid 46 (12.3) 14 (13.9) 11 (14.3) 21 (10.7) 
   Self-insured/self-pay 4 (1.1) 2 (2.0) 0 (0.0) 2 (1.0) 
   Other/unknown 1 (0.3) 0 (0.0) 0 (0.0) 1 (0.5) 
Prior diagnosis of skin 
cancer/cancer precursor*  
159 
(42.4) 
10 (9.9) 20 (26.0) 129 (65.5) 
<0.001 
Dermatology visits in past 5 
years, n (%) 
    
 
   0-2 79 (21.1) 32 (31.7) 20 (26.0) 27 (13.7) 
<0.001 
   3-5 105 
(28.0) 
32 (31.7) 24 (31.2) 49 (24.9) 
   > 5 191 
(50.9) 
37 (36.6) 33 (42.9) 121 (61.4) 
Skin biopsies in past 5 years, n 
(%) 
    
 
   0-2 329 
(87.7) 
96 (95.0) 71 (92.2) 162 (82.2) 
0.004 
   3-5 35 (9.3) 5 (5.0) 6 (7.8) 24 (12.2) 
   > 5 11 (2.9) 0 (0.0) 0 (0.0) 11 (5.6) 
*melanoma (lifetime), keratinocyte skin cancer (lifetime), and actinic keratosis (lifetime) 90 
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Table 2: Most preferred learning preferences and most important sources of information about 92 
decisions for skin growth treatment 93 
Learning 
Preferences 
All respondents Millennials Generation X Baby Boomers & 
The Silent 
Generation 
 
 No. n (%) 
most 
preferre
d* 
No. n (%) 
most 
preferred  
No. n (%) 
most 
preferred  
No. n (%) 
most 
preferred  
p-
value 
In-person 369 311 
(84.3) 
100 77 (77.0) 76 64 (84.2) 193 170 
(88.1) 
0.014 
Diagrams/charts 332 48 
(14.5) 
98  21 (21.4) 72 8 (11.1) 162  19 (11.7) 0.042 
Short handouts 337 39 
(11.6) 
97 10 (10.3) 73 4 (5.5) 167 25 (15.0) 0.17 
Short videos 336 35 
(10.4) 
98 7 (7.1) 71 4 (5.6) 167 24 (14.4) 0.043 
Phone 335 27 (8.1) 98 8 (8.2) 72  5 (6.9) 165 14 (8.5) 0.89 
Information 
Sources 
No. n (%) 
importa
nt† 
No. n (%) 
important 
No. n (%) 
important 
No. n (%) 
important 
p-
value 
Doctors 373 370 
(99.2) 
100 99 (99.0) 77 76 (98.7) 196 195 
(99.5) 
0.60 
Past experiences 292 189 
(64.7) 
88 64 (72.7) 58 38 (65.5) 146 87 (59.5) 0.041 
Personal 
preferences 
331 183 
(55.3) 
99 64 (64.6) 72 42 (58.3) 160 77 (48.1) 0.008 
Friends/family 329 74 
(22.5) 
99 33 (33.3) 72 17 (23.6) 158 24 (15.2) <0.001 
Other patients 329 73 
(22.2) 
98 31 (31.6) 72 18 (25.0) 159  24 (15.1) 0.002 
p-value from Cochran-Armitage trend tests 94 
* most preferred = 5 95 
† important= 4 or 5 96 
